The Medical, Social, and Financial Dimensions of Orphan Drugs

RGA 6216 4 Quarter Hours
Course Level CPS - Graduate
Description Examines the orphan drug development process, from discovery to FDA regulatory approval to postapproval marketing and distribution. Using selected case studies, offers students an opportunity to gain a strong understanding of how novel biomedical discoveries are translated into products used to treat relatively rare diseases. Topics include the role of patient advocacy groups in lobbying for research and development, the influence of gender and racial considerations on policy decisions, and the capacity of the federal government to support the research and commercialization of orphan drugs. The course situates its study of orphan drugs within the context of pharmaceutical firms’ reluctant shift away from big blockbuster drugs in favor of more personalized medicines.


Students should refer to the CPS Prerequisite Table for course prerequisite and corequisite information.


Course Sections

Section 05
CRN 20299
View Syllabus Download
Session Winter 2018 CPS Quarter - Full Term
Class Meeting Dates 01/08/2018 to 03/31/2018
Instructor Lori Fiorentino
Campus Online Campus
Course Format Online
Costs Course Cost: View Tuition Rates | Books: Visit NU Bookstore Site
Next Term Starts
  • Summer Graduate
    Jul 10, 2017 (4-, 6-, and 8-week classes)
    Aug 7, 2017 (4-week classes)
  • Fall Undergraduate
    Sep 4, 2017 (7.5- and 15-week classes)
    Oct 25, 2017 (7.5-week classes)
  • Fall Graduate
    Sep 18, 2017 (6- and 12-week classes)
    Oct 30, 2017 (6-week classes)

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.


Call Toll Free:
Contact Us